Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Eargo, Inc.
  6. Summary
    EAR   US2700871096

EARGO, INC.

(EAR)
  Report
Real-time Estimate Cboe BZX  -  05/26 11:42:24 am EDT
1.255 USD   +18.40%
05/24EARGO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/24Eargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13EARGO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2022 05/23/2022 05/24/2022 05/25/2022 05/26/2022 Date
1.25(c) 1.17(c) 1.04(c) 1.06(c) 1.3 Last
719 453 543 002 586 172 495 652 588 940 Volume
-2.34% -6.40% -11.11% +1.92% +22.64% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 119 M - -
Net income 2022 - - -
Net cash position 2022 147 M - -
P/E ratio 2022 -
Yield 2022 -
Sales 2023 115 M - -
Net income 2023 - - -
Net cash position 2023 147 M - -
P/E ratio 2023 -
Yield 2023 -
Capitalization 41,7 M 41,7 M -
EV / Sales 2022 -0,89x
EV / Sales 2023 -0,92x
Nbr of Employees 243
Free-Float 86,1%
More Financials
Company
Eargo, Inc. is a medical device company that provides Eargo solution to create a hearing aid. The Company’s in-the-canal devices feature audio, are designed to provide up to 16 hours of battery life and have Flexi Fibers or Flexi Palms, which are designed to enable the unit to float in the ear canal, allowing air and sound to pass freely around them. In addition, Eargo hearing aids allows its users to cycle... 
Read more
More about the company
Ratings of Eargo, Inc.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
D
More Ratings
All news about EARGO, INC.
05/24EARGO, INC. Management's Discussion and Analysis of Financial Condition and Results of..
AQ
05/24Eargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13EARGO, INC. Management's Discussion and Analysis of Financial Condition and Results of..
AQ
05/13EARGO, INC. Management's Discussion and Analysis of Financial Condition and Results of..
AQ
05/13EARGO, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa..
AQ
05/13Eargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
05/13Eargo Announces Receipt of Nasdaq Non-Compliance Letter
GL
05/13Eargo Announces Receipt of Nasdaq Non-Compliance Letter
AQ
05/13Eargo, Inc. Auditor Raises 'Going Concern' Doubt
CI
05/12Top Premarket Decliners
MT
05/09Nuheara Names New US-based CEO
MT
05/02TRANSCRIPT : Eargo, Inc. - Special Call
CI
05/02EARGO : Provides Business Update - Form 8-K
PU
05/02EARGO, INC. : Entry into a Material Definitive Agreement, Results of Operations and Financ..
AQ
04/29Eargo Finalizes Agreement with the United States to Resolve Investigation with No Admis..
CI
More news
News in other languages on EARGO, INC.
05/24Eargo, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
05/13Eargo, Inc. annonce ses résultats pour l'année complète se terminant le 31 décembre 202..
05/13Eargo, Inc. Le vérificateur remet en question la continuité de l'entreprise
05/09Nuheara nomme un nouveau PDG basé aux États-Unis
01/18Eargo, Inc. promeut Mark Thorpe au poste de directeur de la comptabilité
More news
Analyst Recommendations on EARGO, INC.
More recommendations
Chart EARGO, INC.
Duration : Period :
Eargo, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EARGO, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 1,06 $
Average target price 10,50 $
Spread / Average Target 891%
Managers and Directors
Christian Gormsen President, Chief Executive Officer & Director
Adam Laponis Chief Financial Officer
Joshua Makower Non-Executive Chairman
Daniel Shen Chief Clinical & Science Officer
Fernando Cruz Vice President-Software & Engineering
Sector and Competitors
1st jan.Capi. (M$)
EARGO, INC.-79.22%42
THERMO FISHER SCIENTIFIC-17.75%209 146
DANAHER CORPORATION-23.92%179 203
INTUITIVE SURGICAL, INC.-38.05%79 897
SIEMENS HEALTHINEERS AG-18.32%64 383
EDWARDS LIFESCIENCES CORPORATION-25.24%60 217